Cases 21 - 30 of 134
FENNEC PHARMACEUTICALS, INC. et al v. CIPLA LIMITED, et al.
as 2:2023cv00123
Plaintiff:
FENNEC PHARMACEUTICALS, INC. and OREGON HEALTH AND SCIENCE UNIVERSITY
Defendant:
CIPLA LIMITED and CIPLA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
GW RESEARCH LIMITED v. TEVA PHARMACEUTICALS, INC. et al
as 2:2023cv00018
Plaintiff:
GW RESEARCH LIMITED
Defendant:
TEVA PHARMACEUTICALS, INC., APOTEX INC., PADAGIS US LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
FRATERNAL ORDER OF POLICE, MIAMI LODGE 20, INSURANCE TRUST FUND et al v. CELGENE CORPORATION et al
as 2:2022cv06694
Plaintiff:
FRATERNAL ORDER OF POLICE, MIAMI LODGE 20, INSURANCE TRUST FUND and JACKSONVILLE POLICE OFFICERS AND FIRE FIGHTERS HEALTH INSURANCE TRUST
Defendant:
CELGENE CORPORATION, BRISTOL-MYERS SQUIBB COMPANY, NATCO PHARMA LIMITED and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED et al v. ELI LILLY AND COMPANY
as 1:2022cv01130
Plaintiff:
Orbicular Pharmaceutical Technologies Private Limited and CIPLA USA, INC.
Defendant:
ELI LILLY AND COMPANY
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
PAR PHARMACEUTICAL, INC. et al v. CIPLA LIMITED et al
as 3:2022cv02814
Plaintiff:
PAR PHARMACEUTICAL, INC., PAR STERILE PRODUCTS, LLC and ENDO PAR INNOVATION COMPANY, LLC
Defendant:
CIPLA LIMITED and CIPLA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PAR PHARMACEUTICAL, INC. et al v. CIPLA LIMITED et al
as 2:2022cv02814
Plaintiff:
PAR PHARMACEUTICAL, INC., PAR STERILE PRODUCTS, LLC and ENDO PAR INNOVATION COMPANY, LLC
Counter Claimant:
CIPLA LIMITED
Defendant:
CIPLA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Gilead Sciences, Inc. v. Lupin Ltd. et al
as 1:2022cv00615
Plaintiff:
Gilead Sciences, Inc.
Defendant:
Lupin Ltd., Laurus Labs Limited and Cipla Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Cipla USA, Inc. v. Ipsen Biopharmaceuticals, Inc.
as 1:2022cv00552
Plaintiff:
Cipla USA, Inc.
Defendant:
Ipsen Biopharmaceuticals, Inc.
Cause Of Action: 15 U.S.C. § 1125 Trademark Infringement (Lanham Act)
Cipla Ltd. v. Boehringer Ingelheim Pharmaceuticals Inc. et al
as 1:2022cv00300
Plaintiff:
Cipla Ltd.
Defendant:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Acerta Pharma B.V. et al v. Cipla Limited et al
as 1:2022cv00162
Plaintiff:
Acerta Pharma B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP and others
Defendant:
Cipla Limited and Cipla USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
